464 related articles for article (PubMed ID: 31869863)
1. The role of biologics in chronic rhinosinusitis: a systematic review.
Iqbal IZ; Kao SS; Ooi EH
Int Forum Allergy Rhinol; 2020 Feb; 10(2):165-174. PubMed ID: 31869863
[TBL] [Abstract][Full Text] [Related]
2. Adverse events of biological therapy in chronic rhinosinusitis with nasal polyps: A systematic review.
Aldajani A; Alroqi A; Alromaih S; Aloulah MO; Alsaleh S
Am J Otolaryngol; 2022; 43(6):103615. PubMed ID: 36057193
[TBL] [Abstract][Full Text] [Related]
3. The Role of Biologics in the Treatment of Nasal Polyps.
Franzese CB
Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
[TBL] [Abstract][Full Text] [Related]
4. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
[TBL] [Abstract][Full Text] [Related]
5. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J
J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083
[TBL] [Abstract][Full Text] [Related]
6. Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study.
Bajpai S; Marino MJ; Rank MA; Donaldson AM; O'Brien EK; Lal D
Int Forum Allergy Rhinol; 2021 Aug; 11(8):1152-1161. PubMed ID: 33527730
[TBL] [Abstract][Full Text] [Related]
7. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
Hardison SA; Senior BA
J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
[TBL] [Abstract][Full Text] [Related]
8. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai).
Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB
ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094
[TBL] [Abstract][Full Text] [Related]
9. Updates on current evidence for biologics in chronic rhinosinusitis.
Nasta MS; Chatzinakis VA; Georgalas CC
Curr Opin Otolaryngol Head Neck Surg; 2020 Feb; 28(1):18-24. PubMed ID: 31789925
[TBL] [Abstract][Full Text] [Related]
10. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
Patel GB; Peters AT
Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
[TBL] [Abstract][Full Text] [Related]
11. Biologics for chronic rhinosinusitis with nasal polyps.
Bachert C; Zhang N; Cavaliere C; Weiping W; Gevaert E; Krysko O
J Allergy Clin Immunol; 2020 Mar; 145(3):725-739. PubMed ID: 32145872
[TBL] [Abstract][Full Text] [Related]
12. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis.
Brown WC; Senior B
Curr Allergy Asthma Rep; 2020 Apr; 20(6):16. PubMed ID: 32323067
[TBL] [Abstract][Full Text] [Related]
13. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis.
Wu Q; Zhang Y; Kong W; Wang X; Yuan L; Zheng R; Qiu H; Huang X; Yang Q
Int Arch Allergy Immunol; 2022; 183(3):279-288. PubMed ID: 34607329
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody therapy in sinonasal disease.
Chiarella SE; Sy H; Peters AT
Am J Rhinol Allergy; 2017 Mar; 31(2):93-95. PubMed ID: 28281440
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
[TBL] [Abstract][Full Text] [Related]
16. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
Geng B; Dilley M; Anterasian C
Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
[TBL] [Abstract][Full Text] [Related]
17. [Progress of monoclonal antibody treatment for chronic rhinosinusitis with or without nasal polyps].
Chen YJ; Chai XB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(10):789-793. PubMed ID: 29873221
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of switching between biologics in chronic rhinosinusitis with nasal polyps or N-ERD.
Brkic FF; Liu DT; Klimbacher R; Campion NJ; Bartosik TJ; Vyskocil E; Stanek V; Tu A; Arnoldner T; Bangert C; Gangl K; Eckl-Dorna J; Schneider S
Rhinology; 2023 Aug; 61(4):320-327. PubMed ID: 37515811
[TBL] [Abstract][Full Text] [Related]
19. Is there a future for biologics in the management of chronic rhinosinusitis?
Lam K; Kern RC; Luong A
Int Forum Allergy Rhinol; 2016 Sep; 6(9):935-42. PubMed ID: 27103607
[TBL] [Abstract][Full Text] [Related]
20. Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review.
Kim C; Han J; Wu T; Bachert C; Fokkens W; Hellings P; Hopkins C; Lee S; Mullol J; Lee JT
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):57-66. PubMed ID: 32746710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]